Skip to main content

Day: November 14, 2019

Flow Capital Announces 2019 Third Quarter Results

– Records Recurring Revenues from Royalties and Interest of $1.3 million and Free Cash Flow(1) of $1.5 million in Q3 2019 –TORONTO, Nov. 14, 2019 (GLOBE NEWSWIRE) — Flow Capital Corp. (TSXV: FW) (“Flow Capital”) today announced its financial and operating results for the three-month and nine-month periods ended September 30, 2019. Financial references are in Canadian dollars unless otherwise specified.2019 Third Quarter HighlightsClosed the raising of $10 million capital through Flow’s Priority Return Fund LPFactor 75 investment bought-out and mCloud note repaid with $4,619,000 of capital returnedRecurring revenue from royalties and interest of $1,340,000Adjusted EBITDA(1) of $1,717,000Free Cash Flow(1) of $1,477,000Completed on October 17, 2019, a substantial issuer bid cancelling 5,708,000 common shares at a cost of $1,142,000Announced...

Continue reading

Avis Budget Group Announces Role as Founding Partner of Urban Movement Labs, Driving Transportation Innovation in Los Angeles

PARSIPPANY, N.J., Nov. 14, 2019 (GLOBE NEWSWIRE) — Avis Budget Group announces today it is one of the founding partners behind Urban Movement Labs, a first-of-its-kind public-private partnership to accelerate transportation innovation launched by Los Angeles Mayor Eric Garcetti. This unprecedented venture will focus on developing, testing and rolling out innovative transit solutions and addressing core challenges around climate change, technology and workforce development in Los Angeles.Urban Movement Labs (UML) brings together the diverse players needed to successfully implement the next generation of mobility solutions to ensure a sustainable, equitable and accessible future for transportation in Los Angeles, and to generate learnings to be replicated in urban environments around the world. Within Los Angeles alone, Avis Budget...

Continue reading

Syncora Holdings Ltd. Announces Third Quarter 2019 Interim GAAP Consolidated Financial Results

HAMILTON, Bermuda, Nov. 14, 2019 (GLOBE NEWSWIRE) — Syncora Holdings Ltd. (“SHL” or the “Company”), a Bermuda holding company whose wholly-owned subsidiary provides financial guarantee insurance and reinsurance, today reported financial results for the nine months ended September 30, 2019 and 2018.          During the third quarter of 2019, as a result of the announced agreement to sell SGI to Star Insurance Holdings LLC, the Company presented SGI as held-for-sale on the consolidated balance sheets as of September 30, 2019 and December 31, 2018, and the results of SGI as discontinued operations in the consolidated statements of operations for the nine months ended September 30, 2019 and 2018. Financial ResultsConsolidated Statements of OperationsFee revenue was $4.2 million for the nine months ended September 30, 2019, as compared...

Continue reading

Chembio Diagnostics to Participate in Upcoming Investor Conferences

MEDFORD, N.Y., Nov. 14, 2019 (GLOBE NEWSWIRE) — Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leading point-of-care diagnostics company focused on infectious diseases, announced today the company plans to participate in two upcoming investor conferences.Management is scheduled to present at the Canaccord Genuity MedTech & Diagnostics Forum in New York, New York on Thursday, November 21, 2019 at 3:00 pm ET. Interested parties may access a live or recorded webcast of the presentation on the “Investor” section of the company’s website at www.chembio.com.  Management is also scheduled to participate in the Benchmark Discovery One-on-One Conference in New York, New York on Wednesday, December 4, 2019. Due to the format of this event no webcast is available.About Chembio DiagnosticsChembio is a leading point-of-care diagnostics company...

Continue reading

Grieg Seafood ASA: Update on the allegations of anti-competitive practices

With reference to the previously announced European Commission inspection which concerned possible collusion between Norwegian producers of farmed Norwegian Atlantic salmon and class action complaints in the USA related to the same matter.Further to this, Grieg Seafood ASA has been informed that the two US-based subsidiaries of Ocean Quality AS, Ocean Quality USA, Inc, and Ocean Quality Premium Brands, Inc. have received a subpoena from the Antitrust Division of the Department of Justice in the USA, where they are opening a criminal investigation involving allegations of similar conduct.Grieg Seafood ASA and Ocean Quality AS are not aware of any kind of practices that support the allegations, or other practices that undermines competition in either the EU or the US.Grieg Seafood ASA and Ocean Quality AS will fully cooperate with the Department...

Continue reading

Lincoln Educational Services Corporation Increases Liquidity and Strengthens Balance Sheet to Leverage Growth Opportunities; Completes $60 Million New Credit Facility and Raises $12.7 Million in Private Placement of Convertible Preferred Stock

WEST ORANGE, N.J., Nov. 14, 2019 (GLOBE NEWSWIRE) — Positioning itself for future growth opportunities, Lincoln Educational Services Corporation (Nasdaq: LINC) completed two financing transactions increasing liquidity by approximately $35 million and bolstering its balance sheet.   The additional liquidity provided by these transactions will strengthen the Company’s balance sheet and provide flexibility to execute long-term growth initiatives such as expansion of existing high demand programs, the addition of new programs with strong employer demand and the expansion of the existing call center which reaches prospective students throughout the country.  In addition, the Company plans to explore strategic acquisitions consistent with the Company’s core business, upgrade training equipment to enhance the student experience, and increase...

Continue reading

Lifeway Foods, Inc. Announces Third Quarter 2019 Results

MORTON GROVE, Ill., Nov. 14, 2019 (GLOBE NEWSWIRE) — Lifeway Foods, Inc. (Nasdaq: LWAY) (“Lifeway” or “the Company”), the leading U.S.  supplier of kefir and fermented probiotic products to support the microbiome, today reported financial results for the third quarter ended September 30, 2019.“Our third quarter results reflect our commitment to our strategic long-term plan to meaningfully reinvigorate growth,” said Julie Smolyansky, CEO of Lifeway Foods, Inc. “While we continue to implement changes in our organizational structure to build for the future and create efficiencies, we also remain focused on increasing brand awareness, driving new product innovation and strengthening consumer loyalty. We are thrilled major retailers nationwide have chosen Plantiful to enhance their healthy consumable product offerings. We believe this...

Continue reading

Terrace Global Inc. Announces Completion of Its Qualifying Transaction

TORONTO, Nov. 14, 2019 (GLOBE NEWSWIRE) — Terrace Global Inc. (“Terrace Global” or the “Corporation”), formerly Apolo II Acquisition Corp. (“Apolo”), is pleased to announce the completion of its qualifying transaction (the “Qualifying Transaction”).Trading in the common shares of Apolo was previously halted on November 12, 2018 at the request of Apolo upon announcement of the Qualifying Transaction. Trading in the common shares of the Corporation (the “Resulting Issuer Shares”) is expected to commence on the TSX Venture Exchange (the “TSXV”) at market open on Monday, November 18, 2019 under the symbol “TRCE”, following the issuance by the TSXV of its final bulletin in respect of the Qualifying Transaction.Pursuant to the terms of the Qualifying Transaction, Apolo acquired all of the issued and outstanding shares (the “Terrace Shares”)...

Continue reading

Agile Therapeutics Announces FDA Extension of Twirla® NDA Review Period

PRINCETON, N.J., Nov. 14, 2019 (GLOBE NEWSWIRE) — Agile Therapeutics, Inc. (Nasdaq: AGRX), a women’s healthcare company, today announced that the U.S. Food and Drug Administration (FDA) has extended the Prescription Drug User Fee Act (PDUFA) goal date for its review of the New Drug Application (NDA) of Twirla® (levonorgestrel/ethinyl estradiol) transdermal system, an investigational combined hormonal contraceptive patch, from November 16, 2019 to February 16, 2020.On October 30, 2019, the FDA’s Bone, Reproductive, and Urologic Drugs Advisory Committee (BRUDAC) met to discuss the benefits and risks of Twirla and voted 14 to 1, with one abstention, that the benefits of Twirla (AG200-15) in the prevention of pregnancy outweigh the risks to support approval.  Although the FDA considers the non-binding recommendation of this panel, the...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.